Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
It seems like SweetBiotix has reason to be optimistic amidst the negative buzz surrounding sweeteners. According to GBN, an official statement addressing the recent concerns about aspartame will be released on June 14th. The fact that this statement is being made implies that food industry lobbyists are already trying to manage public perception. My intuition tells me that there will likely be a softening of the language used to discuss aspartame.
I believe Coca Cola has been involved for years, possibly as far back as 2018, when the initial buzz saw the SP rocket to 130p within days of the interview I did with SOH.
It is good to see the floor, and with the feeling, the bad news is out in the open, renewed confidence the worse is behind OPTI - hence the speculative buying on Friday.
If you do not understand the significant nature of yesterday's RNS, then I would argue POLB is too complicated for you. It was a highly significant RNS that opened many out-license doors with one or multiple big pharma. Perhaps you were expecting one of those to coincide. :)
https://lemminginvestor.substack.com/p/poolbeg-pharma-plc-484
Mol,
I presented a hypothesis and a logical explanation for any potential sales of SBTX from OPTI stock, which could be utilised to fund new product development and territorial launches, while also maintaining capital reserves. This is all purely speculative, of course. Somewhere in there is an element of defence of SOH's position given the current situation. In hindsight, I should not have laboured too much of the past, especially a large part of the reason for this is that the number of shares in SBTX rose from 128m to 173m (35%) during this time from SBTX placings. If OPTI didn’t sell any shares it would now hold a 28% holding. I neglected to revisit this key fact.
I am always prepared to hold my hands up for mistakes, and errors.
My hypothesis does appear to have been misplaced.
The World Health Organization is planning to release two new reports on the safety of aspartame, the popular artificial sweetener in drinks like Diet Coke and Diet Pepsi, on July 14.
https://luminews.my/news/1379489
Howdy, Al,
It seems like we have differing opinions on the matter. While it's a possibility, I highly doubt that a founding institution would be selling their shares at this point. However, only time will reveal the truth. Nonetheless, I stand by my original hypothesis for now. The reason being that, without any concrete evidence to the contrary, I believe that OPTI needs funds to support the growth of its prebiotic sales. This would involve covering the costs of production, shipping, and other expenses. Additionally, it could be a while before any revenue is generated from the sale of the end product - ranging from 9 months to over a year. Given SOH's past experiences with Optipharma and H&B, I believe that he will be cautious with his cash resources and ensure that he maintains liquidity in his cash flow to avoid any last-minute rush placements. It's also likely that he will want to preserve his current cash reserves to the best of his ability.
I hope you do not think I have been rude or abusive towards you. I always try to be respectful, but on occasions a chuck in a little bit of banter.
Al,
I’d wager it’s much simpler than your hypothesis. A TR1 from OPTI is my hypothesis. I’d wager they are under 18%. We should have had it by now! So, maybe you’re on to something?
I’d like an explanation how you arrived at “ He's sitting on a 30% return.” Like who and how you’ve arrived at a 30 profit? TIA.
I have a theory of why troll-like creatures (Oelric, Nick, Phatstyle) behave as they do...like petulant children. They were starved of breast milk.
I believe some of the symptoms are;
never accept ownership of their mistakes, failings
blame others for them
hold a grudge forever
usually negative
cry a lot
whine even more
ungrateful
lie often
keyboard warriors
love elrico - bless xxx
Lord knows what I suckled on? I don't think Trooper was a brew, then. :)
Aquae,
Please forgive me if I have missed a point or two. As far as I can recall, SOH has never made any promises. However, he has provided revenue guidance on multiple occasions, and from what I remember, it has been reasonably accurate. I cannot recall any instances where he has over-promised. However, in 2018, there may have been some uber-bullish information regarding SweetBiotix commercialisation in a Q&A with me. I do not believe this was deliberate - the whole process has taken several years longer than SOH expected. The share price reached 130p shortly after a Q&A with SOH, which TW retweeted. Next, he advised his subscribers to bank their profits. Even then, SOH advised against selling at that time.
You’re sacked!
https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-3e5
"If anything, you could see it as a positive; it might focus more energy on bringing a revolutionary product to the cosmetic market to help boost revenues."
This requires vision, which may require an eye test. I recommend Vision Express for its superior customer service, truth and honesty you do not always get at Phats establishments. :)
Captain Hindsight, I retract my previous statement about you never experiencing a loss.
Your research has a major weakness as it lacks substantial revenues OVER MULTIPLE YEARS, easily providing your assertion to be untrue. I do not wish to spend any more time on this matter. I am afraid that this comment alone may cause investors to view you as an untrustworthy individual, and they may choose to filter you out of future discussions.
Good day to you, Captain Hindsight.
Well done, Captain Hindsight.
Both Companies are fledglings with disruptive technology. 99% of AIM Companies are driven by news (hype) which is part of the strategy required to gain attention from prospective clients/partners/distributors, etc.
Many investors have experienced both gains and losses. The key is to balance expectations while maintaining patience for future opportunities. OPTI and SBTX have reliable technology and products that are commercially feasible and scientifically validated.
It's not wise to seek attention by trolling investors, as it only makes you come across as foolish and lacking empathy for them. It's likely that you have never experienced a loss yourself. :)